172 related articles for article (PubMed ID: 8122376)
1. Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells.
Duan L; Oakes JW; Ferraro A; Bagasra O; Pomerantz RJ
Virology; 1994 Mar; 199(2):474-8. PubMed ID: 8122376
[TBL] [Abstract][Full Text] [Related]
2. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes.
Fang J; Acheampong E; Dave R; Wang F; Mukhtar M; Pomerantz RJ
Virology; 2005 Jun; 336(2):299-307. PubMed ID: 15892970
[TBL] [Abstract][Full Text] [Related]
3. Controlling elements in replication of the human immunodeficiency virus type 1.
Li X; Quan Y; Wainberg MA
Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):443-54. PubMed ID: 9193800
[TBL] [Abstract][Full Text] [Related]
4. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H; Callison D; Li P; Burrell C
Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
6. [RNA ligands for HIV proteins].
Iwai S
Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1430-7. PubMed ID: 7568944
[No Abstract] [Full Text] [Related]
7. Inhibition of HIV-1 by a double transdominant fusion gene.
Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
9. RNA-sequence-mediated gene regulation in HIV-1.
Cullen BR
Infect Agents Dis; 1994; 3(2-3):68-76. PubMed ID: 7812657
[TBL] [Abstract][Full Text] [Related]
10. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
[TBL] [Abstract][Full Text] [Related]
11. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
Natarajan V; Radjendirane V; Salzman NP
Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
13. The tat gene and protein of the human immunodeficiency virus type 1.
Caputo A; Grossi MP; Rossi C; Campioni D; Balboni PG; Corallini A; Barbanti-Brodano G
New Microbiol; 1995 Jan; 18(1):87-110. PubMed ID: 7760763
[No Abstract] [Full Text] [Related]
14. Requirement of an additional Sam68 domain for inhibition of human immunodeficiency virus type 1 replication by Sam68 dominant negative mutants lacking the nuclear localization signal.
Zhang J; Liu Y; Henao J; Rugeles MT; Li J; Chen T; He JJ
Gene; 2005 Dec; 363():67-76. PubMed ID: 16236470
[TBL] [Abstract][Full Text] [Related]
15. The cytotoxicity of human immunodeficiency virus type 1 Rev: implications for its interaction with the nucleolar protein B23.
Miyazaki Y; Takamatsu T; Nosaka T; Fujita S; Martin TE; Hatanaka M
Exp Cell Res; 1995 Jul; 219(1):93-101. PubMed ID: 7628555
[TBL] [Abstract][Full Text] [Related]
16. Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.
Duan L; Zhu M; Ozaki I; Zhang H; Wei DL; Pomerantz RJ
Gene Ther; 1997 Jun; 4(6):533-43. PubMed ID: 9231069
[TBL] [Abstract][Full Text] [Related]
17. [Regulatory mechanism of HIV gene expression].
Hatanaka M
Nihon Rinsho; 1993 Sep; 51 Suppl():43-57. PubMed ID: 8271415
[No Abstract] [Full Text] [Related]
18. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 latency due to the site of proviral integration.
Winslow BJ; Pomerantz RJ; Bagasra O; Trono D
Virology; 1993 Oct; 196(2):849-54. PubMed ID: 8372452
[TBL] [Abstract][Full Text] [Related]
20. Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication.
Verhoef K; Koper M; Berkhout B
Virology; 1997 Oct; 237(2):228-36. PubMed ID: 9356335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]